Interleukin Genetics Files Form 15
August 14, 2017 10:20 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has filed a Form 15 with the Securities and Exchange Commission completing the process of...
Interleukin Genetics Files Form 25
August 04, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 04, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has filed a Form 25 with the Securities and Exchange Commission in furtherance of its...
Interleukin Genetics to Wind-Up and Pursue a Plan of Liquidation
July 24, 2017 16:29 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the adoption of a plan to wind-up and liquidate the Company subject to shareholder approval...
Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce
July 03, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., July 03, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced that it will pursue strategic alternatives for the Company and will reduce the Company’s...
Interleukin Genetics Reports First Quarter 2017 Financial Results
May 12, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., May 12, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its first quarter of 2017, ended March 31, 2017, and provided a...
Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results
April 18, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 18, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, today announced financial and...
Interleukin-1 Genotypes Are Predictive of Cardiovascular Events in Patients With Elevated Lipoprotein (a)
March 20, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 20, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today the presentation...
Interleukin Genetics Signs Second Employer Agreement in Pittsburgh Region
March 13, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 13, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
March 02, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 02, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
Interleukin Genetics Deploys ILUSTRA™ Inflammation Management Program with mPulse Mobile Employees
February 23, 2017 08:00 ET
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...